Annual Current Assets
$4.43 M
+$2.74 M+162.30%
December 31, 2023
Summary
- As of February 12, 2025, KRBP annual total current assets is $4.43 million, with the most recent change of +$2.74 million (+162.30%) on December 31, 2023.
- During the last 3 years, KRBP annual current assets has fallen by -$6.31 million (-58.75%).
- KRBP annual current assets is now -83.63% below its all-time high of $27.07 million, reached on December 31, 2021.
Performance
KRBP Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$4.30 M
-$1.72 M-28.60%
September 30, 2024
Summary
- As of February 12, 2025, KRBP quarterly total current assets is $4.30 million, with the most recent change of -$1.72 million (-28.60%) on September 30, 2024.
- Over the past year, KRBP quarterly current assets has dropped by -$1.72 million (-28.60%).
- KRBP quarterly current assets is now -88.02% below its all-time high of $35.92 million, reached on September 30, 2021.
Performance
KRBP Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
KRBP Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +162.3% | -28.6% |
| 3 y3 years | -58.8% | -8.7% |
| 5 y5 years | +690.8% | -8.7% |
KRBP Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -83.6% | +162.3% | -84.1% | +154.8% |
| 5 y | 5-year | -83.6% | +162.3% | -88.0% | +178.8% |
| alltime | all time | -83.6% | +690.8% | -88.0% | +178.8% |
Kiromic BioPharma Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.30 M(-28.6%) |
| Jun 2024 | - | $6.03 M(+8.2%) |
| Mar 2024 | - | $5.57 M(+25.7%) |
| Dec 2023 | $7.74 M(-24.7%) | $4.43 M(-25.4%) |
| Sep 2023 | - | $5.94 M(+26.0%) |
| Jun 2023 | - | $4.71 M(+34.0%) |
| Mar 2023 | - | $3.52 M(+108.2%) |
| Dec 2022 | $10.28 M | $1.69 M(-21.0%) |
| Sep 2022 | - | $2.14 M(-73.4%) |
| Jun 2022 | - | $8.03 M(-52.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $16.73 M(-38.2%) |
| Dec 2021 | $3.66 M(+75.1%) | $27.07 M(-24.6%) |
| Sep 2021 | - | $35.92 M(+810.2%) |
| Jun 2021 | - | $3.95 M(-49.7%) |
| Mar 2021 | - | $7.85 M(-26.9%) |
| Dec 2020 | $2.09 M(+241.4%) | $10.74 M(+595.8%) |
| Sep 2020 | - | $1.54 M(-39.0%) |
| Jun 2020 | - | $2.53 M(-22.2%) |
| Mar 2020 | - | $3.25 M(+59.5%) |
| Dec 2019 | $612.30 K(+93.9%) | $2.04 M |
| Dec 2018 | $315.80 K | - |
FAQ
- What is Kiromic BioPharma annual total current assets?
- What is the all time high annual current assets for Kiromic BioPharma?
- What is Kiromic BioPharma annual current assets year-on-year change?
- What is Kiromic BioPharma quarterly total current assets?
- What is the all time high quarterly current assets for Kiromic BioPharma?
- What is Kiromic BioPharma quarterly current assets year-on-year change?
What is Kiromic BioPharma annual total current assets?
The current annual current assets of KRBP is $4.43 M
What is the all time high annual current assets for Kiromic BioPharma?
Kiromic BioPharma all-time high annual total current assets is $27.07 M
What is Kiromic BioPharma annual current assets year-on-year change?
Over the past year, KRBP annual total current assets has changed by +$2.74 M (+162.30%)
What is Kiromic BioPharma quarterly total current assets?
The current quarterly current assets of KRBP is $4.30 M
What is the all time high quarterly current assets for Kiromic BioPharma?
Kiromic BioPharma all-time high quarterly total current assets is $35.92 M
What is Kiromic BioPharma quarterly current assets year-on-year change?
Over the past year, KRBP quarterly total current assets has changed by -$1.72 M (-28.60%)